Big pharma’s billion-dollar bets

1 London

London News & Search

1 News - 1 eMovies - 1 eMusic - 1 eBooks - 1 Search

Learn more at https://bigdeal.ft.com/
Why is big pharma paying billions to take over small companies? Arash Massoudi, the FT’s corporate finance and deals editor, explains that as patents expire and the pressure to cut R&D costs rises, large pharmaceutical companies are being forced to make risky bets in search of the next blockbuster drug.


1 London

London News & Search

1 News - 1 eMovies - 1 eMusic - 1 eBooks - 1 Search


Facebooktwittergoogle_plusredditpinterestlinkedinmail

Facebooktwittergoogle_pluslinkedinrssyoutube

Leave a Reply